Skip to content

Dossier · APPN · Dormant

APPN · Appian Corporation · Stock research

Last analysed ·

Current thesis

Process-orchestration-for-AI-agents narrative re-rating a de-rated low-code name: Q2 on 2026-08-06 put cloud subscription revenue +23% YoY and lifted FY26 revenue guidance to $845–853M. Timing is the problem — RSI 70.2 after a 58% three-month run, spot above two of three targets raised the same week, and no scheduled event until the ~November Q3 print.

Invalidation trigger

A weekly close below $31 unwinds the 2026-08-06/07 earnings gap and returns price to the pre-print range; secondary confirmation would be FY26 revenue guidance reduced from the $845–853M range at the Q3 report.

Thesis status

Open commitment scored if the trigger above fires How this is scored →

Latest analysis and events for APPN —

As of 2026-08-09, orbyd's latest analysis for Appian Corporation (APPN): Process-orchestration-for-AI-agents narrative re-rating a de-rated low-code name: Q2 on 2026-08-06 put cloud subscription revenue +23% YoY and lifted FY26 revenue guidance to $845–853M. Timing is the problem — RSI 70.2 after a 58% three-month run, spot above two of three targets raised the same week, and no scheduled event until the ~November Q3 print.

Invalidation trigger: A weekly close below $31 unwinds the 2026-08-06/07 earnings gap and returns price to the pre-print range; secondary confirmation would be FY26 revenue guidance reduced from the $845–853M range at the Q3 report.

Current Thesis

The leg on offer is "process orchestration is the layer enterprise AI agents need," attached to a software name whose growth had stalled and is now reaccelerating. Q2 2026, reported 2026-08-06, put cloud subscription revenue at $131.7M (+23% YoY) against total revenue of $203.256M (+19.1% YoY, versus $193.498M consensus), and management lifted the FY26 revenue range to $845–853M from $819–831M. The AI attach is quantified rather than gestured at: customer Appian AI usage was 20x the year-ago quarter and 85% of Q2 new logos bought the AI offering. Against that, the stock closed $34.64 on 2026-08-07 with RSI(14) at 70.2 after a 58.0% three-month run, and there is no company-scheduled event until the Q3 print roughly three months out.

Bullish and bearish views on Appian Corporation

The model's bull view on Appian Corporation (APPN), in brief: Cloud subscription revenue $131.7M in Q2 2026, +23% YoY — growing faster than the 19.1% total, which mixes the company toward its higher-quality line (Q2 2026 release, 2026-08-06). The bear view: Billings were $197.4M in Q2 2026, +7.4% YoY — far below the 19.1% revenue growth the print was celebrated for. Both cases follow in full.

Bull Case

  • Cloud subscription revenue $131.7M in Q2 2026, +23% YoY — growing faster than the 19.1% total, which mixes the company toward its higher-quality line (Q2 2026 release, 2026-08-06).
  • FY26 revenue guidance raised to $845–853M from $819–831M against $826.29M consensus; FY26 adjusted EPS raised to $1.04–1.12 from $0.94–1.05 against $0.99 consensus (2026-08-06).
  • FY26 cloud subscription revenue guided to $525–529M, about 20% growth at the midpoint, with adjusted EBITDA of $104–110M implying roughly a 13% margin (2026-08-06).
  • Profitability inflected: Q2 adjusted EPS $0.13 versus $0.00 consensus, adjusted EBITDA $16.16M (7.9% margin), GAAP operating margin -2.7% against -6.4% a year earlier.
  • Q3 guide sits above the Street on both lines: revenue $214–218M versus $207.936M estimate, adjusted EPS $0.31–0.35 versus $0.32 estimate; the cloud subscription component is $133–135M, ~18% YoY at the midpoint.
  • Marks moved from the skeptics, not just the bulls: Citigroup Buy, PT to $40 (2026-08-07); Morgan Stanley Equal-Weight, PT to $32 (2026-08-07); DA Davidson Neutral, PT to $34 (2026-08-08).
  • Unquantified legal optionality remains alive: the 2022 jury award of $2.036B against Pegasystems was vacated and a new trial ordered, affirmed unanimously by the Supreme Court of Virginia on 2026-01-08, with the retrial venued in Fairfax County Circuit Court.

Bear Case

  • Billings were $197.4M in Q2 2026, +7.4% YoY — far below the 19.1% revenue growth the print was celebrated for. Billings lead recognized revenue, so the forward-demand line is running well under the reported line.
  • Net revenue retention 115% in Q2 2026 — expansion is healthy but not at the level that historically supports a re-rating in mid-cap software.
  • GAAP operating margin is still negative at -2.7%; the profitability story rests on adjusted figures.
  • The 2026-08-07 close of $34.64 is above two of the three targets set within 48 hours of the print — Morgan Stanley's $32 and DA Davidson's $34. Only Citigroup's $40 sits above spot.
  • The $2.036B award is not on any schedule. Pegasystems' public case-status page, checked 2026-08-09, states no retrial date has been set and notes that rehearing petitions could delay proceedings further.
  • Structurally the name is still repairing: $34.64 sits 24.1% under the $45.64 52-week high. The three-month move has been a recovery inside a damaged longer-term chart, not a breakout to new highs.

Setup & Price Structure

  • Price basis: $34.64 close on 2026-08-07; 52-week high $45.64; distance from high -24.1%; three-month return +58.0%; RSI(14) 70.2.
  • The reference structure is the 2026-08-06/08-07 earnings gap. Benzinga's same-day write-up on 2026-08-06 described shares dipping on the release; the adjusted close the following session was $34.64, so the gap held and extended rather than filling.
  • Life-cycle label: ACCELERATING, dated to the 2026-08-06 print and the three price-target raises on 2026-08-07 and 2026-08-08. New numbers, new marks, expanding coverage attention. It is not SATURATED — the sell-side is still clustered at Neutral and Equal-Weight, and price has not reclaimed the 52-week high.
  • Crowding and positioning observables, stated without a verdict: RSI(14) 70.2 into a +58.0% three-month move; spot above two of three freshly raised targets; monthly founder-CEO Form 4 sales on a plan adopted March 2026; no earnings date inside 30 days, so no near-term binary to reprice into.
  • Entering at these levels means paying for the guidance raise after the sell-side already marked to it, with the next scheduled proof point roughly a quarter away.

Catalyst Calendar (next 30 days)

  • 2026-08-09 → 2026-09-08: no company-scheduled event confirmed as of 2026-08-09. The 30-day window is empty of binaries.
  • ~2026-09-08 (est.): next monthly Rule 10b5-1 Form 4 from the founder-CEO, extrapolating the 2026-06-08 and 2026-07-07 filing cadence. Share count and print price are observable on filing.
  • Unscheduled: Fairfax County Circuit Court scheduling order in Appian v. Pegasystems. No trial date exists as of 2026-08-09.
  • ~2026-11-05 (est.): Q3 2026 report — the first test of the $214–218M revenue / $0.31–0.35 adjusted EPS guide and of whether cloud subscription growth holds the ~18% midpoint.

What Would Change Our Mind

The structure that matters is the 2026-08-06/08-07 earnings gap; losing it says the raise did not hold a bid. Concretely, a weekly close below $31 returns price to the pre-print range and ends the post-earnings re-rating leg. On fundamentals, the number to watch is billings: a second consecutive quarter near the Q2 +7.4% pace, while revenue growth decelerates toward it, would say the 19% print was a recognition artifact rather than fresh demand. A reduction of the FY26 revenue range from $845–853M at the Q3 report would do the same faster. Separately, if the ~2026-11-05 print comes and goes without a beat-and-raise and the sell-side stays parked at Neutral/Equal-Weight, the label moves to MATURING and the case for paying up here weakens. Finally, if a Fairfax retrial date is set far out or the case settles for a fraction of the vacated $2.036B, whatever legal optionality is embedded in the price gets marked down on a known day.

Correlation Notes

  • Pegasystems (PEGA) is the closest read-across on two axes at once: same process-automation and low-code end market, and the counterparty in the vacated $2.036B judgment. PEGA datapoints on BPM demand move APPN's fundamental read; PEGA legal headlines move the optionality.
  • ServiceNow (NOW) and Salesforce (CRM) set the tone for the "agents need an orchestration layer" framing. Agentic-workflow commentary from either is a sector-level input to APPN's narrative, and both are also competitive threats to the same budget line.
  • APPN behaves as high-beta mid-cap software. It correlates with IGV-type baskets and, given GAAP losses, carries duration sensitivity to the long end of the curve.
  • The target dispersion is narrow around spot — $32, $34 and $40, all set 2026-08-07/08 — leaving little published upgrade headroom for momentum flow to chase.

Notes

  • Dual-class structure: public float is Class A; the founder-CEO's Class B supervoting stake means Class A holders have limited voting influence.
  • The $2.036B 2022 jury award against Pegasystems is vacated, not collectible; any value ascribed to it depends on a retrial with no scheduled date.
  • Founder-CEO share sales run under a Rule 10b5-1 plan adopted March 2026, so monthly Form 4s are plan-driven and not discretionary decisions.
  • Fiscal year is the calendar year; Q3 results are typically reported in late October or early November.

Related · shared themes

HPE

Hewlett Packard Enterprise Company

Five straight up sessions took HPE to a $53.22 close on 2026-08-07 with the 2026-08-04 gap floor at $50.24 still untested; Trefis put the five-day move at +19.8% against +5.6% for the S&P 500, so this leg is no longer pure sector beta. Forward P/E 13.79 versus 49.66 trailing. The still-unconfirmed ~2026-09-02 Q3 print against the $11.5–12.1B / $0.88–0.93 guide is the binary.

MEDIUM

OKTA

Okta, Inc.

Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme ACCELERATING, this leg maturing; open risk is paying up for a stretched 52-week-high tape.

MEDIUM

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW

SNX

TD SYNNEX Corporation

The 2026-08-04 breakout above the July band failed within three sessions — SNX closed $252.42 on 2026-08-07, back inside the $235.67–$255.70 range and under the 50-day. The move up came on Arista's print, not company news; Hyve's +117% billings leg stays unconfirmed until ~2026-09-24, and the nearest dated read is Dell on 2026-09-03.

LOW

See also · stocks to watch